Ruxolitinib对JAK2V617F阳性骨髓增殖性肿瘤细胞基质金属蛋白酶调控的研究

OBJECTIVE: To investigate the regulation of JAK2 tyrosine kinase inhibitor ruxolitinib on extracellular matrix metalloproteinase (MMP in JAK2V617F positive myeloproliferative neoplasms (MPN) cells. METHODS: ①Forty cases of newly diagnosed JAK2V617F positive MPN patients and 15 healthy volunteers as...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354179/
https://www.ncbi.nlm.nih.gov/pubmed/28279039
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.02.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354179/
https://www.ncbi.nlm.nih.gov/pubmed/28279039
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.02.011

Ejemplares similares